Antimicrobial resistance research and intervention alliance

Antimicrobial resistance (AMR) poses a major global health threat, with South and Southeast Asia being regions that are particularly affected by the spread of resistant pathogens. Carbapenems are a class of antibiotics often used as a last-resort treatment against multidrug-resistant bacteria. Thus the emergence of carbapenem-resistant Gram-negative bacilli (CR-GNB) is of critical concern. Carbapenem-resistent Enterobacterales (CRE) — particularly Klebsiella pneumoniae and Escherichia coli — spread readily in healthcare and community settings, while carbapenem-resistant Acinetobacter baumannii (CRAB) is primarily confined to hospital settings, especially in intensive-care units (ICUs). Both CRE and CRAB cause severe infections opportunistically, with high mortality rates and limited treatment options. CRE often colonize healthy individuals asymptomatically and transiently, but transmission to an immunocompromised patient can result in severe infection, making it crucial to understand how a healthy gut microbiome confers colonization resistance against these opportunistic pathogens.

Considering Singapore’s growing burden of CR-GNB infections, the Antimicrobial Resistance Research and Intervention Alliance Singapore (AMRITAS) programme was established to improve overall outcomes for CR-GNB infections through treatment optimization and prevention. AMRITAS encompasses two research themes:

Theme 1: Establish a regional clinical trial platform that utilizes a novel adaptive design to identify and implement optimal treatments for severe CR-GNB infections

Theme 2: Elucidate the factors driving CRE transmission and evolution within the human gut to develop microbiome-based strategies for preventing colonization and infection

As part of Theme 2, our lab works closely with collaborators from NUS, NTU, and TTSH to:

  • discover key elements of carbapenem resistance spread in the gut microbiome
  • identify key species and metabolic pathways that promote resistance to CRE colonization
  • test strategies for CR-GNB colonization resistance in germ-free mice

Read more:

Antimicrobial resistance research and intervention alliance
Older post

Understanding the impact of antibiotic consumption on the gut microbiome

Leveraging a new longitudinal cohort and novel sequencing methods, we're diving into the impact of antibiotics consumptions on the gut microbiome

Newer post

AI on the hunt: finding tomorrow's viruses today

Finding viruses in environmental samples is a major public health challenge. Our SurVirAR platform uses Artificial Intelligence to identify viral sequences from complex data. These sequences are then assembled into complete genomes, creating a deployable early warning system for future pandemics.

Antimicrobial resistance research and intervention alliance